A drug already sold for other prostate problems significantly cut the chances of prostate cancer being found in men with an increased risk of the disease, doctors reported Monday. The U.S. study was led by WUSTL urologic surgeon Gerald Andriole, who comments.

References:

1. April 27, 2009 — Study: Drug lowers risk of getting prostate cancer in the Associated Press

and 52 others.

Richard Knox reports on the results of two prostate cancer screening studies that were designed to answer the question: Would men who got regular PSA tests have less risk of dying from prostate cancer? The answer — maybe. The author of the new U.S. study, WUSTL urologic surgery professor Gerald Andriole, comments.

References:

1. March 18, 2009 — No Clear Answer In Studies of Prostate-Cancer Test in the NPR All Things Considered

The PSA blood test, used to screen for prostate cancer, saves few lives and leads to risky and unnecessary treatments for large numbers of men, two large studies have found. The findings, the first based on rigorous, randomized studies, confirm some longstanding concerns about the wisdom of widespread prostate cancer screening. Includes comments by WUSTL urologic surgery professor Gerald Andriole, lead author of the U.S. study.

References:

1. March 19, 2009 — Studies Show Prostate Test Saves Few Lives in the The New York Times

and 1 others.

Science is not shy about ambiguity, never more so than when it comes to medical advice. New research has found seemingly contradictory conclusions of prostate cancer screenings. WUSTL urologic surgery professor Gerald Andriole, who participated in one of the studies, comments.

References:

1. March 19, 2009 — Prostate Exams: When Are They Necessary? in the Time

Some doctors say they're disappointed that experts are offering men relatively little guidance about whether to be screened for prostate cancer and shifting the decision onto men who may have trouble making sense of such complicated research. Lead author of the U.S. study, WUSTL urologic surgery professor Gerald Andriole, comments.

References:

1. March 19, 2009 — Studies cast doubt on leading prostate cancer test in the USA Today

The largest prostate cancer screening program in U.S. history is showing high compliance and consistent results. The authors, led by Dr. Gerald L. Andriole at Washington University School of Medicine in St. Louis, Missouri, found that after the third annual follow-up round, compliance with screening had decreased only slightly, to 85%, from 89% at baseline.

References:

1. Jan. 1, 2009 — With annual prostate cancer screening, new cases are less advanced in the Reuters Health Medical News

An experimental blood test for prostate cancer may help eliminate tens of thousands of unnecessary biopsies at the same time that it detects many tumors that are now missed by the test commonly used, Johns Hopkins researchers said yesterday.
WUSTL urology professor Gerald Andriole, who is chief of urologic surgery, said that "if the data hold up, this marker will be a substantial improvement over PSA."

References:

1. April 26, 2007 — New Prostate Cancer Test May Detect More Tumors in the The Washington Post

and 3 others.

Researchers at WUSTL School of Medicine and several other institutions are engaged in a massive study to see if current screening practices can cut the number of deaths from prostate cancer.

References:

1. March 16, 2005 — Best way to find prostate cancer found in the United Press International

and 4 others.

School of Medicine urologist Gerald Andriole comments on a new drug used to treat an enlarged prostate that apparently also offers men a reduced risk for developing prostate cancer.

References:

1. Oct. 15, 2004 — Prostate drug might cut cancer risk in the Reuters (UK)

and 1 others.